| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.62B | -10.4% |
| Cost of Revenue | $2.55B | +16.2% |
| Gross Profit | $69.9M | -90.4% |
| R&D Expense | $112.8M | +13.8% |
| SG&A Expense | $164.7M | -3.3% |
| Operating Income | -$27.2M | -104.6% |
| Interest Expense | $12.2M | -6.7% |
| Pre-tax Income | $8.6M | -98.5% |
| Income Tax | $52.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.48B | +2.1% |
| Accounts Receivable | $324.3M | -24.5% |
| Inventory | $621.4M | -6.7% |
| Current Assets | $3.79B | +18.8% |
| Total Assets | $8.25B | +11.3% |
| Current Liabilities | $1.04B | +42.8% |
| Long-term Debt | $185.0M | -25.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $873.4M | +267.6% |
| Capital Expenditures | $903.6M | +67.2% |
| Investing Cash Flow | -$1.19B | -1104.1% |
| Financing Cash Flow | $309.4M | +663.0% |
| Free Cash Flow | -$30.2M | +90.0% |
| -49.0% |
| Net Income | -$44.2M | -109.4% |
| EPS (Basic) | -$0.41 | -109.3% |
| EPS (Diluted) | -$0.41 | -109.4% |
| Total Liabilities |
| $2.42B |
| +66.1% |
| Stockholders' Equity | $5.84B | -2.1% |